Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

This study has been completed.
Procter and Gamble
Information provided by:
Novartis Identifier:
First received: June 30, 2005
Last updated: January 23, 2008
Last verified: January 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2006
  Estimated Primary Completion Date: No date given